Review Article
Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future Applications
Table 2
Therapeutic agents delivered by SC for the treatment of HGG.
| Agent delivered | Type of stem cells | ESC | NSC | MSC |
| Cytokines | Mda-7/IL24, TRAIL | IL-4, IL-12, IL-23, TRAIL +/− BMZ, and S-TRAIL +/− MIR/TMZ | IL-2, IL-12, IL-18, INFα, INF-β, and TRAIL +/− PI3KI |
| Enzyme/prodrug | | Tk/GCV, CD/5FC +/− IFNβ | Tk/GCV |
| Viral particles | | Mutant HSV-1, CRAd-survivin | CRAd-survivin, CRAd-CXCR4, and CRAd-Rb |
| Metalloproteinases | | PEX | |
| Antibodies | | | EGFRvIII |
| Nanoparticles | | | Ferrociphenol lipid |
|
|